Anaphylaxis and Mast Cell Disorders.
Anaphylaxis
D816 V mutation
Hereditary alpha-tryptasemia
Mast cell activation syndromes
Mast cell hyperreactivity
Mastocytosis
Tryptase
Journal
Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
entrez:
26
11
2021
pubmed:
27
11
2021
medline:
5
1
2022
Statut:
ppublish
Résumé
There is strong evidence of an association between severe anaphylaxis, especially hymenoptera venom induced, and mast cell (MC) disorders. It has been thought that intrinsic abnormalities in MCs, including the presence of the activating KIT D816V mutation in mastocytosis or of genetic trait, hereditary alpha-tryptasemia, may influence susceptibility to severe anaphylaxis. This article evaluates the potential mechanisms leading to severe MC activation, as well as the differential diagnosis of and range of symptoms attributable to MC mediator release. Also, we offer a global classification for disorders related to MC activation.
Identifiants
pubmed: 34823750
pii: S0889-8561(21)00082-5
doi: 10.1016/j.iac.2021.09.007
pii:
doi:
Substances chimiques
Arthropod Venoms
0
Tryptases
EC 3.4.21.59
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
45-63Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure T. Gülen has received lecture fees from Thermo Fisher. C. Akin has received consultancy fees from Blueprint Medicines and Novartis and has a patent for LAD2 cells.